Ameriprise Financial said pretax income for the 3 months ended March 31, 2025 decreased $532 million, or 44%, compared to the prior year period. The company said the market impact on non-traditional long-duration products, net of hedges and the reinsurance accrual, was an expense of $460 million compared to a benefit of $140 million in the prior year period.

1. 01

   Ameriprise Financial said pretax income for the 3 months ended March 31, 2025 decreased $532 million, or 44%, compared to the prior year period. The company said the market impact on non-traditional long-duration products, net of hedges and the reinsurance accrual, was an expense of $460 million compared to a benefit of $140 million in the prior year period.

2. 02

   Management and financial advice fees for Q1 2025 increased $203 million, or 8%, compared to the prior year period, Ameriprise Financial said. The company said market appreciation and wrap account net inflows were reflected, while the cumulative impact of Asset Management net outflows and higher performance fees in the prior year period partially offset the increase.

3. 03

   Total AUM as of March 31, 2025 increased $19.5 billion, or 2%, to $1.1 trillion compared to the prior year period, Ameriprise Financial said. The company said Advice & Wealth Management AUM increased $51.0 billion and Asset Management AUM decreased $30.7 billion primarily driven by net outflows.

4. 04

   Ameriprise Financial said it paid $148 million in regular quarterly dividends for Q1 2025 and repurchased 1.2 million shares at an average price of $525.76 per share. As of March 31, 2025, the company had $271 million remaining under the existing share repurchase authorization, and on April 22, 2025 its Board of Directors authorized an additional $4.5 billion for share repurchases.

Key figures

Quarter ended March 31, 2025

Revenue

$4.5B

Net income

$583M

EPS

$5.83

Operating cash flow

$1.7B

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.